Kikuchi K, Oyama G, Shimoda S, et al. Dopaminergic medication alters muscle synergy during sit-to-stand motion in Parkinson's disease. Frontiers in Neurology. 2026. Original article
This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.
DOI: 10.3389/fneur.2026.1753476
Bibliographic record from the original reports
Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.
Kikuchi K, Oyama G, Shimoda S, et al. Dopaminergic medication alters muscle synergy during sit-to-stand motion in Parkinson's disease. Frontiers in Neurology. 2026. Original article
Conditions: COND-PD Parkinson’s disease
Scoped audit evidence
These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.
Parkinson’s disease — transfer
- access status: primary_body
14 analyzed of 20 measurements; selected participants with daily wearing-OFF ≥1 hour and a planned levodopa challenge. OFF-state STS and seat-off durations longer.
Limitations: Only the enumerated transfer-relevant components were adjudicated. Source availability does not imply every statement, supplement, figure or raw datum was checked.
Reports citing this source
- Sit to stand and functional transfer assessment and prognosis in Parkinson’s disease · reference 46 · original reference
Update record
- 2026-10-03: Created from the supplied reports and final scoped audit. New evidence should be appended with source version, access date, exact locator and affected report links.
Updating the wiki · Evidence and status guide